Gene · 571
Papers2,758
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,758
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Innate and adaptive immune evasion by dengue virus. | Front Cell Infect Microbiol | 2022 | 36189361 | PubTator, text mining | PubMed |
| Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. | Front Immunol | 2022 | 36189286 | PubTator, text mining | PubMed |
| Lupus nephritis: The regulatory interplay between epigenetic and MicroRNAs. | Front Physiol | 2022 | 36187762 | PubTator, text mining | PubMed |
| Identifying potential therapeutic targets for ischemic stroke through immune infiltration analysis and construction of a programmed cell death‑related ceRNA network. | Exp Ther Med | 2022 | 36185765 | PubTator, text mining | PubMed |
| BTB domain and CNC homolog 1 promotes glioma invasion mainly through regulating extracellular matrix and increases ferroptosis sensitivity. | Biochim Biophys Acta Mol Basis Dis | 2022 | 36181980 | PubTator, text mining | PubMed |
| Identification of the effects of COVID-19 on patients with pulmonary fibrosis and lung cancer: a bioinformatics analysis and literature review. | Sci Rep | 2022 | 36163484 | PubTator, text mining | PubMed |
| Ferroptosis: A mixed blessing for infectious diseases. | Front Pharmacol | 2022 | 36160441 | PubTator, text mining | PubMed |
| Exosomes and exosomal miRNAs: A new therapy for intervertebral disc degeneration. | Front Pharmacol | 2022 | 36160436 | PubTator, text mining | PubMed |
| AntiVIRmiR: A repository of host antiviral miRNAs and their expression along with experimentally validated viral miRNAs and their targets. | Front Genet | 2022 | 36159991 | PubTator, text mining | PubMed |
| Research Progress on the Effect of Traditional Chinese Medicine on Signal Pathway Related to Premature Ovarian Insufficiency. | Evid Based Complement Alternat Med | 2022 | 36159578 | PubTator, text mining | PubMed |
| Protective effects and regulatory pathways of melatonin in traumatic brain injury mice model: Transcriptomics and bioinformatics analysis. | Front Mol Neurosci | 2022 | 36157079 | PubTator, text mining | PubMed |
| Identification of the Transcription Factor ATF3 as a Direct and Indirect Regulator of the LDLR. | Metabolites | 2022 | 36144244 | PubTator, text mining | PubMed |
| Role of RBMS3 Novel Potential Regulator of the EMT Phenomenon in Physiological and Pathological Processes. | Int J Mol Sci | 2022 | 36142783 | PubTator, text mining | PubMed |
| Micro-Players of Great Significance-Host microRNA Signature in Viral Infections in Humans and Animals. | Int J Mol Sci | 2022 | 36142450 | PubTator, text mining | PubMed |
| mintRULS: Prediction of miRNA-mRNA Target Site Interactions Using Regularized Least Square Method. | Genes (Basel) | 2022 | 36140696 | PubTator, text mining | PubMed |
| Genome-Scale CRISPR Knockout Screening Identifies BACH1 as a Key Regulator of Aflatoxin B1-Induced Oxidative Damage. | Antioxidants (Basel) | 2022 | 36139865 | PubTator, text mining | PubMed |
| Harnessing the Therapeutic Potential of the Nrf2/Bach1 Signaling Pathway in Parkinson's Disease. | Antioxidants (Basel) | 2022 | 36139853 | PubTator, text mining | PubMed |
| Low Concentrations of Oxidized Phospholipids Increase Stress Tolerance of Endothelial Cells. | Antioxidants (Basel) | 2022 | 36139816 | PubTator, text mining | PubMed |
| Biomarker Genes Discovery of Alzheimer's Disease by Multi-Omics-Based Gene Regulatory Network Construction of Microglia. | Brain Sci | 2022 | 36138932 | PubTator, text mining | PubMed |
| Fbxo22 promotes cervical cancer progression via targeting p57Kip2 for ubiquitination and degradation. | Cell Death Dis | 2022 | 36127346 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/571/papers?page=31